down arrow

Wave Life Sciences Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SG9999014716
USD
7.62
0.63 (9.01%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Verve Therapeutics, Inc.
Adaptive Biotechnologies Corp.
Wave Life Sciences Ltd.
Kura Oncology, Inc.
Curis, Inc.
Novavax, Inc.
Inhibrx, Inc.
Kymera Therapeutics, Inc.
Apogee Therapeutics, Inc.
Sana Biotechnology, Inc.
Cassava Sciences, Inc.
Why is Wave Life Sciences Ltd. ?
1
Flat results in Jun 25
  • NET SALES(HY) At USD 17.87 MM has Grown at -44.54%
  • OPERATING CASH FLOW(Y) Lowest at USD -201.93 MM
  • PRE-TAX PROFIT(Q) At USD -50.47 MM has Fallen at -53.29%
2
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -50.10%, its profits have fallen by -81.4%
3
Underperformed the market in the last 1 year
  • Even though the market (S&P 500) has generated returns of 12.33% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -50.10% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Wave Life Sciences Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Wave Life Sciences Ltd.
-45.73%
0.37
70.88%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
49.64%
EBIT Growth (5y)
5.10%
EBIT to Interest (avg)
-120.80
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.31
Sales to Capital Employed (avg)
1.15
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
93.76%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
6.19
EV to EBIT
-6.98
EV to EBITDA
-7.50
EV to Capital Employed
-15.81
EV to Sales
8.36
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-62.52%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
NET SALES(9M)

Higher at USD 101.62 MM

NET PROFIT(9M)

Higher at USD -68.09 MM

CASH AND EQV(HY)

Highest at USD 451.56 MM

-18What is not working for the Company
NET SALES(HY)

At USD 17.87 MM has Grown at -44.54%

OPERATING CASH FLOW(Y)

Lowest at USD -201.93 MM

PRE-TAX PROFIT(Q)

At USD -50.47 MM has Fallen at -53.29%

NET PROFIT(Q)

At USD -50.47 MM has Fallen at -53.29%

RAW MATERIAL COST(Y)

Grown by 16.15% (YoY

Here's what is working for Wave Life Sciences Ltd.
Cash and Eqv
Highest at USD 451.56 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Depreciation
Highest at USD 2.2 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Wave Life Sciences Ltd.
Net Sales
At USD 17.87 MM has Grown at -44.54%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (USD MM)

Pre-Tax Profit
At USD -50.47 MM has Fallen at -53.29%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -50.47 MM has Fallen at -53.29%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Cash Flow
Lowest at USD -201.93 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Raw Material Cost
Grown by 16.15% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."